| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.06▼ | 2.06▼ | 2.06▼ | 2.05▼ | 2.39▼ |
| MA10 | 2.05▼ | 2.05▼ | 2.05▼ | 2.15▼ | 2.65▼ |
| MA20 | 2.06▼ | 2.06▼ | 2.08▼ | 2.38▼ | 2.80▼ |
| MA50 | 2.16▼ | 2.16▼ | 2.19▼ | 2.70▼ | 1.94▲ |
| MA100 | 2.21▼ | 2.33▼ | 2.40▼ | 2.81▼ | 1.40▲ |
| MA200 | 2.41▼ | 2.56▼ | 2.65▼ | 2.24▼ | 4.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.007▲ | 0.007▲ | -0.030▼ | -0.170▼ |
| RSI | 41.337▼ | 40.934▼ | 39.094▼ | 30.005▼ | 40.544▼ |
| STOCH | 74.074 | 66.270 | 62.566 | 13.040▼ | 14.231▼ |
| WILL %R | -50.000 | -50.000 | -50.000 | -89.796▼ | -94.774▼ |
| CCI | -40.767 | -17.983 | -27.556 | -84.070 | -197.096▼ |
|
Friday, September 19, 2025 04:36 AM
Dr. Uttam Patil, ABVC's Chief Executive Officer, stated: "This US$145,950 licensing payment from OncoX brings our total OncoX receipts in Q3 to nearly US$600,000 and underscores the current strength ...
|
|
Thursday, August 14, 2025 04:12 AM
Abvc BioPharma operates at the intersection of pharmaceutical research and nature-based medicine, developing new drugs using botanical sources. The company’s core business lies in carrying drug and ...
|
|
Wednesday, May 14, 2025 06:15 AM
SILICON VALLEY, CA - May 14, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/12/25 | 2.055 | 2.09 | 2.04 | 2.04 | 42,095 |
| 17/12/25 | 2.06 | 2.085 | 2.00 | 2.03 | 46,397 |
| 16/12/25 | 2.03 | 2.13 | 1.965 | 2.06 | 83,900 |
| 15/12/25 | 2.11 | 2.23 | 2.03 | 2.03 | 39,723 |
| 12/12/25 | 2.25 | 2.26 | 2.085 | 2.11 | 81,469 |
| 11/12/25 | 2.26 | 2.30 | 2.24 | 2.25 | 72,200 |
| 10/12/25 | 2.20 | 2.28 | 2.19 | 2.23 | 80,600 |
| 09/12/25 | 2.08 | 2.29 | 2.08 | 2.23 | 92,200 |
| 08/12/25 | 2.40 | 2.497 | 2.06 | 2.12 | 169,700 |
| 05/12/25 | 2.53 | 2.576 | 2.32 | 2.41 | 118,200 |
|
|
||||
|
|
||||
|
|